AURKB and cancer: Cancer cells with high HER2 overexpression such as N87, OE19, TE-4, and USPC-ARK2 show substantial apoptotic response to lapatinib treatment, while others with low levels of HER2 overexpression such as MKN7, OE-33, KYSE-410, and ARK4 do not.